Emerinopathy and laminopathy clinical, pathological and molecular features of muscular dystrophy with nuclear envelopathy in Japan.
about
The nuclear envelope: an intriguing focal point for neurogenetic diseaseLamina-associated polypeptide 1: protein interactions and tissue-selective functionsLinker of nucleoskeleton and cytoskeleton complex proteins in cardiac structure, function, and disease.Nuclear localization signal deletion mutants of lamin A and progerin reveal insights into lamin A processing and emerin targetingDiseases of the nuclear envelope.LMNA Sequences of 60,706 Unrelated Individuals Reveal 132 Novel Missense Variants in A-Type Lamins and Suggest a Link between Variant p.G602S and Type 2 DiabetesAssessment of incidental findings in 232 whole-exome sequences from the Baylor-Hopkins Center for Mendelian GenomicsInhibition of extracellular signal-regulated kinase 1/2 signaling has beneficial effects on skeletal muscle in a mouse model of Emery-Dreifuss muscular dystrophy caused by lamin A/C gene mutation.Reduced expression of A-type lamins and emerin activates extracellular signal-regulated kinase in cultured cells.Lamina-associated polypeptide-1 interacts with the muscular dystrophy protein emerin and is essential for skeletal muscle maintenanceDepletion of lamina-associated polypeptide 1 from cardiomyocytes causes cardiac dysfunction in mice.Linker of nucleoskeleton and cytoskeleton complex proteins in cardiomyopathy
P2860
Q27006719-10FDE877-4D18-4A6D-8FDF-926BBF92C7C6Q27694535-C9643881-2358-4EB1-A59A-15BC167AD526Q33551452-4C1F64D5-AE3D-413A-A99B-3D1DFFF42800Q33638752-B2A0A399-088D-4C0E-827B-0A5EC76ECE90Q33687043-BDA54C8D-4139-4BEE-8F61-32283B5E205DQ33799816-F7A93F03-1C3D-46BD-BDC6-171D4C431119Q35832872-9A53A186-8991-474A-9B5C-FD27D7AEFE2AQ36985669-1A9845A9-E4DE-4442-96E5-DF45998B7922Q37106817-DF662FA9-2559-48B0-AD95-2253781EE1CEQ37233110-4D138AD6-8593-42D1-96F6-2A1077F784EDQ42612930-38DD4492-BA73-4E97-B704-18A954C2C60CQ57171613-78784988-A7A5-429E-80E8-4D7B85D541E8
P2860
Emerinopathy and laminopathy clinical, pathological and molecular features of muscular dystrophy with nuclear envelopathy in Japan.
description
2007 nî lūn-bûn
@nan
2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
Emerinopathy and laminopathy c ...... nuclear envelopathy in Japan.
@ast
Emerinopathy and laminopathy c ...... nuclear envelopathy in Japan.
@en
Emerinopathy and laminopathy c ...... nuclear envelopathy in Japan.
@nl
type
label
Emerinopathy and laminopathy c ...... nuclear envelopathy in Japan.
@ast
Emerinopathy and laminopathy c ...... nuclear envelopathy in Japan.
@en
Emerinopathy and laminopathy c ...... nuclear envelopathy in Japan.
@nl
prefLabel
Emerinopathy and laminopathy c ...... nuclear envelopathy in Japan.
@ast
Emerinopathy and laminopathy c ...... nuclear envelopathy in Japan.
@en
Emerinopathy and laminopathy c ...... nuclear envelopathy in Japan.
@nl
P2093
P2860
P1433
P1476
Emerinopathy and laminopathy c ...... h nuclear envelopathy in Japan
@en
P2093
M N Astejada
Y K Hayashi
P2860
P304
P577
2007-12-01T00:00:00Z